News related to Guanfacine and/or conditions it is approved for
Alcon Announces AZARGA(R) Ophthalmic Suspension Approved For Treatment Of Patients With Glaucoma Or Ocular Hypertension In The European Union
Source: Eye Health / Blindness News From Medical News Today [2008.12.04]
Alcon, Inc. (NYSE:ACL) announced today that the European Medicines Agency (EMEA) has approved Alcon's fixed combination eye drop, AZARGA® (brinzolamide 10mg/ml+timolol 5mg/ml) ophthalmic suspension, for treatment of elevated intraocular pressure (IOP) associated with open-angle glaucoma or ocular hypertension in adult patients for whom monotherapy provides insufficient IOP reduction.
Calcium Antagonist Plus ACE Inhibitor Improves Hypertension Outcomes
Source: MedPage Today Cardiovascular [2008.12.03]
ANN ARBOR, Mich. (MedPage Today) -- For high-risk patients with hypertension, combining an ACE inhibitor with a calcium channel blocker improved outcomes compared with an ACE inhibitor plus a diuretic, a multicenter trial showed.
International Medical Team Announces Patient Results In Adult Stem Cell Clinical Study For Pulmonary Hypertension
Source: Hypertension News From Medical News Today [2008.11.27]
Dr. Leonel Fernandez Liriano, Professor of Medicine at Pontifical Catholic University School of Medicine (PCUSM), announced nine month follow up results for the first patient treated with engineered stem cells in a clinical study of primary pulmonary hypertension. The stem cells are extracted from patients' own blood and trained to become new blood vessels. Zannos Grekos, M.D.
Why Does It Take So Long For A Correct Diagnosis Of Pulmonary Hypertension?
Source: Hypertension News From Medical News Today [2008.11.26]
Lack of awareness of pulmonary hypertension is one of the reasons why it takes on average up to two years for a correct diagnosis of this rare lung disease. This year's week-long campaign included a series of national fundraising and press events, organised by the national charity, Pulmonary Hypertension Association UK (www.phassociation.uk.com), and will culminate in the patient annual conference on 14 November.
Hypertension May Hit Black Males Earlier
Source: MedicineNet Exercise and Activity Specialty [2008.11.25]
Title: Hypertension May Hit Black Males Earlier
Category: Health News
Created: 11/25/2008 2:00:00 AM
Last Editorial Review: 11/25/2008
Hypertension Develops Early, Silently, In African-American Men
Source: Hypertension News From Medical News Today [2008.11.18]
Young and healthy African-American men have higher central blood pressure and their blood vessels are stiffer compared to their white counterparts, signs that the African American men are developing hypertension early and with little outward sign, according to a new study.
FREEDOM-C Trial Of Oral Treprostinil In Pulmonary Arterial Hypertension Fails To Meet Primary Endpoint
Source: Hypertension News From Medical News Today [2008.11.18]
United Therapeutics Corporation (Nasdaq: UTHR) announced the results of the FREEDOM-C trial of oral treprostinil, a sustained-release formulation of treprostinil, in pulmonary arterial hypertension (PAH). Preliminary analysis demonstrates that the trial did not achieve statistical significance for the primary endpoint, six minute walk (6MW) distance at Week 16.
Lipoprotein Levels May Predict Women's Hypertension Risk
Source: MedicineNet Cholesterol Specialty [2008.11.12]
Title: Lipoprotein Levels May Predict Women's Hypertension Risk
Category: Health News
Created: 11/12/2008 2:00:00 AM
Last Editorial Review: 11/12/2008
Lipoprotein Levels May Predict Women's Hypertension Risk (HealthDay)
Source: Y! Health Cholesterol News [2008.11.11]
HealthDay - TUESDAY, Nov. 11 (HealthDay News) -- High levels of lipoprotein
particles may increase the risk of high blood pressure in women who
currently have normal blood pressure.
Diabetes, Hypertension Hasten Death in Alzheimer's Patients
Source: MedicineNet Dementia Specialty [2008.11.04]
Title: Diabetes, Hypertension Hasten Death in Alzheimer's Patients
Category: Health News
Created: 11/4/2008 2:00:00 AM
Last Editorial Review: 11/4/2008
Women at Higher Risk for Pulmonary Hypertension
Source: MedicineNet Pulmonary Hypertension Specialty [2008.10.30]
Title: Women at Higher Risk for Pulmonary Hypertension
Category: Health News
Created: 10/30/2008 2:00:00 AM
Last Editorial Review: 10/30/2008
CHEST 2008: New Pulmonary Hypertension Research Presented
Source: Erectile Dysfunction / Premature Ejaculation News From Medical News Today [2008.10.29]
#6363 TADALAFIL PROVES EFFECTIVE THERAPY FOR PULMONARY HYPERTENSION New research shows that the erectile dysfunction drug, tadalafil, may be an effective adjunct therapy for patients with pulmonary arterial hypertension (PAH). Italian researchers randomized 405 patients with PAH, of whom 53 percent were taking concomitant bosentan, to two study arms. The groups received either tadalafil or placebo orally once daily as monotherapy or as add-on therapy to bosentan.
Cialis May Help Ease Pulmonary Hypertension
Source: MedicineNet Impotence (ED) Specialty [2008.10.29]
Title: Cialis May Help Ease Pulmonary Hypertension
Category: Health News
Created: 10/29/2008 2:00:00 AM
Last Editorial Review: 10/29/2008
Pulmonary Hypertension
Source: MedicineNet Fainting Specialty [2008.10.13]
Title: Pulmonary Hypertension
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 10/13/2008
Pseudotumor Cerebri (Idiopathic Intracranial Hypertension)
Source: MedicineNet Brain Tumor Specialty [2008.09.30]
Title: Pseudotumor Cerebri (Idiopathic Intracranial Hypertension)
Category: Diseases and Conditions
Created: 11/8/1998 8:47:00 PM
Last Editorial Review: 9/30/2008
New Molecular Trigger Described for Hypertension, Diabetes
Source: MedicineNet Insulin Resistance Specialty [2008.07.01]
Title: New Molecular Trigger Described for Hypertension, Diabetes
Category: Health News
Created: 7/1/2008 2:00:00 AM
Last Editorial Review: 7/1/2008
Preeclampsia (Pregnancy Induced Hypertension)
Source: MedicineNet Scleroderma Specialty [2008.05.07]
Title: Preeclampsia (Pregnancy Induced Hypertension)
Category: Diseases and Conditions
Created: 11/14/1998 4:06:00 PM
Last Editorial Review: 5/7/2008
New Guidelines Tackle Treatment of Resistant Hypertension
Source: MedicineNet Hyperkalemia Specialty [2008.04.08]
Title: New Guidelines Tackle Treatment of Resistant Hypertension
Category: Health News
Created: 4/8/2008 2:00:00 AM
Last Editorial Review: 4/8/2008
Diuretics Best for Hypertension and Metabolic Syndrome
Source: MedicineNet amlodipine Specialty [2008.01.29]
Title: Diuretics Best for Hypertension and Metabolic Syndrome
Category: Health News
Created: 1/29/2008 2:00:00 AM
Last Editorial Review: 1/29/2008
Portal Hypertension
Source: MedicineNet Transjugular Intrahepatic Portosystemic Shunt Specialty [2005.01.31]
Title: Portal Hypertension
Category: Diseases and Conditions
Created: 1/31/2005 8:20:00 AM
Last Editorial Review: 1/31/2005 8:20:17 AM
Minoxidil: An Underused Vasodilator for Resistant or Severe Hypertension
Source: Medscape Pharmacotherapy Headlines [2004.06.16]
Although minoxidil is a potent vasodilator and will lower blood pressure, there are significant problems that limit its use to resistant hypertension or patients with definite renal disease.
Journal of Clinical Hypertension
Thyroid Function And Structure May Be Altered In Pediatric Obesity
Source: Health News from Medical News Today [2008.12.04]
In addition to its strong associations with hypertension, cardiovascular disease, and diabetes, pediatric obesity may induce alterations in thyroid function and structure, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
Lack Of Vitamin D Could Spell Heart Trouble
Source: Cardiovascular / Cardiology News From Medical News Today [2008.12.03]
Vitamin D deficiency - which is traditionally associated with bone and muscle weakness - may also increase the risk of cardiovascular disease (CVD). A growing body of evidence links low 25-hydroxyvitamin D levels to common CVD risk factors such as hypertension, obesity and diabetes, as well as major cardiovascular events including stroke and congestive heart failure.
Use Of Low-Cost Diuretics To Treat High Blood Pressure Did Not Increase After Study Showing Effectiveness
Source: Hypertension News From Medical News Today [2008.12.02]
The use of low-cost, generic diuretics to treat high blood pressure did not increase significantly following a 2002 study that found the drugs were more effective at treating hypertension than newer drugs that were up to 20 times more expensive, the New York Times reports. The
India minister wants all school kids to learn yoga (Reuters)
Source: Y! Health Diabetes News [2008.11.29]
Reuters - India's health minister on Saturday said he wants to push all school-going children to learn yoga, in the hope that it can reduce the prevalence of diseases such as diabetes and hypertension in years to come.
Thiazide-Induced Hypokalemia May Mediate Increased Diabetes Risk
Source: MedPage Today Cardiovascular [2008.11.25]
BALTIMORE (MedPage Today) -- Thiazide diuretic-induced decreases in serum potassium levels appear to be at least partially responsible for the link between the hypertension drugs and diabetes, researchers here found.
NLH Eyes & Vision Specialist Library Presents The - Annual Evidence Update On Glaucoma, 24th To 30th November 2008
Source: Eye Health / Blindness News From Medical News Today [2008.11.24]
The term "glaucoma" for the purposes of the annual evidence update (AEU) is used to cover primary open angle glaucoma (POAG) and normal tension glaucoma (NTG). Ocular hypertension is also included here as it is a strong risk factor for developing glaucoma.
Metabolex Announces Positive Results From Phase 2 Clinical Trial Of MBX-8025
Source: Cholesterol News From Medical News Today [2008.11.19]
Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced positive results from a Phase 2 clinical trial of MBX-8025. A summary of the results was presented at the World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) on November 1, 2008. MBX-8025 is an oral drug candidate that is being evaluated for the treatment of dyslipidemia.
High Blood Pressure: Over 50 Percent Of People With The Condition Are Unaware They Are Hypertensive
Source: Hypertension News From Medical News Today [2008.11.13]
More than half of people diagnosed with high blood pressure do not have it under control and many more go undiagnosed, according to research carried out at the University of Warwick. Professor Franco Cappuccio from Warwick Medical School at the University of Warwick led the only UK team to participate in a European study examining awareness, treatment and control of high blood pressure, or hypertension.
Is Sildenafil Safe In Cirrhosis Patients?
Source: Hypertension News From Medical News Today [2008.11.13]
Sildenafil is valuable in the treatment of erectile dysfunction and pulmonary hypertension in patients with end-stage liver disease through inhibition of the type-5 phosphodiesterase. The type-5 phosphodiesterase is also present in human mesenteric arteries. The effect of sildenafil on splanchnic blood flow and portal hypertension remains essentially unknown.
Metabolex Announces Positive Results From Phase 1a Clinical Trial Of MBX-2982
Source: Hypertension News From Medical News Today [2008.11.13]
Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced positive results from a Phase 1a clinical trial of MBX-2982. A summary of the results was presented at the World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) on November 1, 2008.
Medication Compliance In African Americans Boosted By Gifts, Affirmations
Source: Compliance News From Medical News Today [2008.11.12]
Study highlights: Phone calls and low-cost gifts to African Americans with hypertension increased how frequently they correctly took their medication. Taking medication consistently and correctly is a major issue in all patient populations and especially African Americans, researchers said.
Link Found Between Obesity And Erectile Dysfunction
Source: Erectile Dysfunction / Premature Ejaculation News From Medical News Today [2008.10.29]
A new study states that obese men with erectile dysfunction (ED) are shown to have low levels of hormones, such as testosterone. The findings also show that certain conditions associated with obesity, particularly hypertension, are the most important determinants of obesity-related ED. The study was published in The Journal of Sexual Medicine, the official journal of the International Society for Sexual Medicine.
Six Sigma Principles Drive Healthcare Behavior Change -- Using Medication Compliance To Improve Healthcare Outcomes
Source: Compliance News From Medical News Today [2008.08.20]
Highlights of a project that demonstrates how employee compliance in taking medication for conditions such as hypertension and diabetes benefits both employee and employer will be presented by Todd Prewitt, M.D., SHPS' director of clinical operations/medical director, and Jill D. Olds, director of global benefit strategy for Cummins Inc. at Harvard University's Quality Colloquium, August 18-21, 2008.
Shock wave therapy for kidney stones linked to diabetes
Source: The Doctors Lounge - Urology
Mayo Clinic researchers are sounding an alert about side effects of shock wave lithotripsy such as diabetes, hypertension.
|
